
结论很明确:这个市场不适合进入,价格战已经成形,且新品牌成功率太低。 现在不是“选品再优化就能做起来”的阶段,而是“多数新品一上来就亏”的阶段;对大品牌和小商家都不友好,尤其小商家如果没有激进投放或强差异化,基本没有稳定胜算。
证据上,市场已经明显偏向过度拥挤:近 20 个新发布里只有 1 个盈利,成功率 5.00%,而亏损新品占 95.00%;利润区间也很差,新发布产品利润大多落在 -23.60% 到 -13.85% 之间。 从品牌数量看,已识别到 6 个新品牌、24 个老品牌,共 30 个品牌在竞争,且新品牌里只有 Liamoy 跑通,其他如 Generic、COUWELL、Duiliuu、TikCode、ZUAVIALA、SUREPHON 都在亏。更关键的是,像 COUWELL 的 B0GSTZ7LW2 利润率 -36.93%,Duiliuu 的 B0GWKT7B4Q 为 -16.52%,SUREPHON 的 B0GMLSL1LK 为 -7.73%,这些都说明这个类目不是健康竞争,而是成本压不住、卖价也抬不起来。同时,Duiliuu 的一个新款出现 303 条评论,属于明显的高压营销样本,不能当作小商家成功案例,反而说明要想硬拼,往往要走非常激进的打法。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这个市场不值得进入。 你的预算 50万CNY 远高于单个新品参考预算 14,105.37 USD,钱够,但市场本身已经是高风险、价格战环境,不适合大品牌,也不适合小商家,因为最近的新入场几乎都在亏,只有极少数靠强营销冲出来的案例。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经明显进入价格战区,而且新品牌存活率极低。 目前可见的新品牌新发布产品里,盈利率只有10%,非盈利率高达90%,而老品牌新发布产品的盈利率是0%、非盈利率是100%,说明不是简单“努力就能做起来”,而是大概率被运输和平台费用压死;再看市场总体,已识别产品里只有1.96%是盈利的,属于非常典型的高风险、低回报市场。
这个市场不值得进入,结论很明确:已经接近/进入过度拥挤状态,且利润被严重压低。 现有数据里,已知利润率产品中有47.06%低于-10%,再加上0%~10%和10%~20%区间几乎没有,说明不是“正常竞争”,而是明显的低利润挤压;新产品里更差,45%低于-10%,只有1个新产品赚钱,新的赚钱比例只有5.00%。
证据很直接:新品牌进入并没有形成健康扩张,而是大量亏损试错。 近一年新进入品牌只有6个,但2026年新上架里,17个是亏损新品、只有1个盈利新品;亏损样本里,COUWELL 的 B0GSTZ7LW2 亏损率 -36.93%,Generic 的 B0GJ6QTMW3 -28.22%,COVERTIFY 的 B0GS9CLL1L -24.16%,TikCode 的 B0GYS2LGY3 -17.53%,Duiliuu 的 B0GWKT7B4Q -16.52%,这不是小商家稳定赚钱的环境,更像是靠频繁上新和硬推硬砸。反过来看,唯一明确成功的是新品牌 Liamoy 的 B0F4D5QWRX,售价 $33.91,月销 900 件,月营收 $30,519,利润率 21.17%,投入预算 $14,105.37;它的成功点是“更高承重+减震降噪+防潮抬高”的功能差异,而不是单纯低价。也就是说,想复制它,至少要准备接近 14,105.37 的单品启动资金,而且这还只覆盖前期采购、物流和营销,不含研发、品牌和认证,真实门槛更高。
最终判断:大品牌和小商家都不适合贸然进入;如果硬要做,大品牌也只能靠重投放+功能创新,小商家没有不靠激进打法的稳定胜算。 这个类目里,现成老品牌样本里大量产品都在亏,且常见失败原因是同质化、市场太小、竞争极端;这意味着它不是“能靠普通选品赚钱”的市场。建议不要进场;如果一定要对标,至少只看 Liamoy 的 B0F4D5QWRX 这种差异化型号,但它不代表低成本可复制路径。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0F4D5QWRX | Liamoy | 2026-01-15 | Yes | $33.91 | 900pcs | $30519.0 | 21.17% | $6460.88 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0F4D5QWRX | Liamoy | 2026-01-15 | Yes | $33.91 | 900pcs | $30519.0 | 21.17% | $6460.88 |
这个市场不值得进入。 结论很直接:新产品成功率只有5.00%,整体可识别盈利产品占比仅1.96%,而且新品牌新发布产品盈利率只有10.00%、老品牌新发布产品盈利率为0.00%,说明这里已经是高竞争、低容错的市场,不是适合稳健切入的机会。
证据很硬:近一段时间新产品几乎都是失败,2026年1月到7月里新发布产品共看到19个非盈利、只有1个盈利;月度上,4月出现5个新产品全部亏损,6月又有5个全部亏损,趋势是失败在放大,而不是机会在扩散。品牌层面也很集中:Liamoy 是唯一明确成功的新品牌,单个ASIN B0F4D5QWRX 以21.2%利润率、月销900、月营收30519美元跑通,但它的打法带有黑帽新发属性,投入总预算14105.37美元,且早期投放就要6561.77美元,说明这不是普通小卖家靠低预算就能复制的路径;相反,SUREPHON、Generic、COVERTIFY、Duiliuu、ZUAVIALA 等多次出现亏损,且大量产品同质化明显,属于价格战+同款堆量环境。小卖家方面,真正能作为健康样本的只有 Liamoy 这一例,且94条评论、900月销、黑帽推广,不能当作“合法低成本成功案例”;如果要合法进入,至少要准备接近14105美元的单品启动资金,还要额外覆盖研发、品牌和认证,500000元预算虽然够门槛,但不代表值得做。
最后一句:不建议推进。 这里不是“谁更聪明谁赚钱”的市场,而是“高投入、低成功率、强同质化”的市场;大品牌和小卖家都没有明显胜算,小卖家若硬进,极可能被迫走激进投放甚至灰色打法。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,已经进入明显的高风险/过度拥挤状态。最近新增新品里几乎全是亏损,成功者极少,而且新品牌成功几乎只剩下极少数带黑帽推广的案例;以现在的节奏,不管大品牌还是小商家,都不是好市场。
证据很直接:近一年新品牌新上架的盈利率只有10%,而非盈利率高达90%;最近几个月新增的新品牌里,4月出现5个非盈利新品、6月又出现5个非盈利新品,说明竞争不是放缓,而是在加速。按品牌看,真正成功的只有Liamoy / B0F4D5QWRX 这一条线,且它并不轻松:售价 35.98美元,当前月销 900,月营收 30,519美元,利润率 21.2%,但启动总预算要到 14,105.37美元,并且明确标记为BLACK_HAT_NEW_RELEASED;反过来,近期开出的失败样本里,Duiliuu / B0GWKT7B4Q、TikCode / B0GYS2LGY3、COUWELL / B0GSTZ7LW2、Generic / B0GJ6QTMW3、B0GK27NZP4、COVERTIFY / B0GS9CLL1L、B0GS86Y5HG、SUREPHON / B0GMLSL1LK、ZUAVIALA / B0G199575S 都在亏损,很多毛利为负,典型是价格战和烧钱拉量。市场趋势也很明确:2025年还有少量可见成功,到了2026年新品牌大量涌入但绝大多数失败,属于新增品牌上升、利润下滑的拥挤局面。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 13 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |